Please enable JavaScript to continue using this application.

Compare $AKTS vs $KURA | Chartloom

Compare

$AKTS vs $KURA

Aktis Oncology Inc · Kura Oncology Inc

AKTS

Aktis Oncology Inc

KURA

Kura Oncology Inc

Compare $AKTS vs $KURA

Comparing Aktis Oncology Inc and Kura Oncology Inc

AKTSAktis Oncology Inc

KURAKura Oncology Inc

AKTSAktis Oncology Inc

Market cap

$969M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

99.47x

Rev growth (TTM)

49.9%

YTD performance

-19.0%

52W performance

18688.8%

FCF yield

-12.6%

KURAKura Oncology Inc

Market cap

$941M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

6.49x

Rev growth (TTM)

-7.3%

YTD performance

2.6%

52W performance

5.2%

FCF yield

-12.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AKTS

KURA

Detailed metrics comparison

AKTS

Aktis Oncology Inc

KURA

Kura Oncology Inc

Market Cap

AKTS$969M

KURA$941M

Enterprise Value

AKTS$887M

KURA$881M

Price

AKTS$18.15

KURA$10.60

P/E Ratio

AKTSN/A

KURAN/A

P/S Ratio

AKTS73.94x

KURA12.18x

EV/Sales

AKTS67.65x

KURA11.40x

EV/EBITDA

AKTS0.00x

KURA0.00x

P/B Ratio

AKTS2.12x

KURA19.56x

P/FCF Ratio

AKTSN/A

KURAN/A

EV/FCF

AKTS-7.29x

KURA-7.50x

PEG Ratio

AKTSN/A

KURAN/A

Forward P/E (NTM)

AKTSN/A

KURAN/A

Forward P/S (NTM)

AKTS99.47x

KURA6.49x

Revenue (TTM)

AKTS$13M

KURA$77M

Revenue Growth (YoY)

AKTS49.9%

KURA-7.3%

Forward Rev Growth

AKTS-9.8%

KURA106.3%

Gross Margin (TTM)

AKTS0.0%

KURA72.4%

Operating Margin (TTM)

AKTS0.0%

KURA0.0%

EBITDA Margin (TTM)

AKTS-934.0%

KURA-410.2%

Net Margin (TTM)

AKTS-810.2%

KURA-384.3%

FCF Margin (TTM)

AKTS-928.1%

KURA-152.1%

Net Income (TTM)

AKTS$-106M

KURA$-297M

FCF (TTM)

AKTS$-122M

KURA$-117M

EPS (TTM)

AKTS-$1.92

KURA-$3.34

ROE (TTM)

AKTS-3080.0%

KURA-20718.0%

ROA (TTM)

AKTS-2531.0%

KURA-4517.0%

ROIC (TTM)

AKTS-3080.0%

KURA-19400.0%

Cash

AKTS$82M

KURA$70M

Debt

AKTS$0

KURA$10M

Net Cash/Debt

AKTS$82M

KURA$60M

Current Ratio (TTM)

AKTS16.33x

KURA4.73x

Quick Ratio (TTM)

AKTS16.10x

KURA4.47x

Debt/Equity (TTM)

AKTS0.00x

KURA0.20x

Debt/Assets (TTM)

AKTS0.0%

KURA0.0%

Interest Coverage (TTM)

AKTSN/A

KURAN/A

Net Debt/EBITDA (TTM)

AKTS0.00x

KURA0.00x

Beta

AKTS160.56

KURA0.53

52W Performance

AKTS18688.8%

KURA5.2%

YTD Performance

AKTS-19.0%

KURA2.6%

% from 52W High

AKTS-46.9%

KURA-23.7%

% from 52W Low

AKTS907400.0%

KURA44.1%

Asset Turnover (TTM)

AKTS0.03x

KURA0.12x

FCF Yield (TTM)

AKTS-12.6%

KURA-12.5%

Earnings Yield (TTM)

AKTS-11.0%

KURA-31.5%

Dividend Yield (TTM)

AKTSN/A

KURAN/A

Rule of 40

AKTS-878.2

KURA-159.3

EV/GP/RG

AKTSN/A

KURA0.09

Ticker research

View AKTS research View KURA research

Metric	AKTS Aktis Oncology Inc	KURA Kura Oncology Inc
Market & Valuation
Market Cap	$969M	$941M
Enterprise Value	$887M	$881M
Price	$18.15	$10.60
P/E Ratio	N/A	N/A
P/S Ratio	73.94x	12.18x
EV/Sales	67.65x	11.40x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.12x	19.56x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.29x	-7.50x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	99.47x	6.49x
Revenue & Growth
Revenue (TTM)	$13M	$77M
Revenue Growth (YoY)	49.9%	-7.3%
Forward Rev Growth	-9.8%	106.3%
Profitability
Gross Margin (TTM)	0.0%	72.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-934.0%	-410.2%
Net Margin (TTM)	-810.2%	-384.3%
FCF Margin (TTM)	-928.1%	-152.1%
Net Income (TTM)	$-106M	$-297M
FCF (TTM)	$-122M	$-117M
EPS (TTM)	-$1.92	-$3.34
ROE (TTM)	-3080.0%	-20718.0%
ROA (TTM)	-2531.0%	-4517.0%
ROIC (TTM)	-3080.0%	-19400.0%
Financial Health
Cash	$82M	$70M
Debt	$0	$10M
Net Cash/Debt	$82M	$60M
Current Ratio (TTM)	16.33x	4.73x
Quick Ratio (TTM)	16.10x	4.47x
Debt/Equity (TTM)	0.00x	0.20x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	160.56	0.53
52W Performance	18688.8%	5.2%
YTD Performance	-19.0%	2.6%
% from 52W High	-46.9%	-23.7%
% from 52W Low	907400.0%	44.1%
Efficiency & Yields
Asset Turnover (TTM)	0.03x	0.12x
FCF Yield (TTM)	-12.6%	-12.5%
Earnings Yield (TTM)	-11.0%	-31.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-878.2	-159.3
EV/GP/RG	N/A	0.09
Ticker research	View AKTS research	View KURA research

Valuation

P/S Ratio

KURA

12.18x

AKTS

73.94x

EV/FCF

KURA

-7.50x

AKTS

-7.29x

Growth & revenue

Revenue Growth TTM

AKTS

49.9%

KURA

-7.3%

Forward Revenue Growth

KURA

106.3%

AKTS

-9.8%

Profitability & performance

Gross Margin

KURA

72.4%

AKTS

0.0%

ROE

AKTS

-3080.0%

KURA

-20718.0%

FCF Yield %

KURA

-12.5%

AKTS

-12.6%

52-Week Performance

AKTS

18688.8%

KURA

5.2%

Detailed metrics comparison

AKTS

Aktis Oncology Inc

KURA

Kura Oncology Inc

Market Cap

AKTS$969M

KURA$941M

Enterprise Value

AKTS$887M

KURA$881M

Price

AKTS$18.15

KURA$10.60

P/E Ratio

AKTSN/A

KURAN/A

P/S Ratio

AKTS73.94x

KURA12.18x

EV/Sales

AKTS67.65x

KURA11.40x

EV/EBITDA

AKTS0.00x

KURA0.00x

P/B Ratio

AKTS2.12x

KURA19.56x

P/FCF Ratio

AKTSN/A

KURAN/A

EV/FCF

AKTS-7.29x

KURA-7.50x

PEG Ratio

AKTSN/A

KURAN/A

Forward P/E (NTM)

AKTSN/A

KURAN/A

Forward P/S (NTM)

AKTS99.47x

KURA6.49x

Revenue (TTM)

AKTS$13M

KURA$77M

Revenue Growth (YoY)

AKTS49.9%

KURA-7.3%

Forward Rev Growth

AKTS-9.8%

KURA106.3%

Gross Margin (TTM)

AKTS0.0%

KURA72.4%

Operating Margin (TTM)

AKTS0.0%

KURA0.0%

EBITDA Margin (TTM)

AKTS-934.0%

KURA-410.2%

Net Margin (TTM)

AKTS-810.2%

KURA-384.3%

FCF Margin (TTM)

AKTS-928.1%

KURA-152.1%

Net Income (TTM)

AKTS$-106M

KURA$-297M

FCF (TTM)

AKTS$-122M

KURA$-117M

EPS (TTM)

AKTS-$1.92

KURA-$3.34

ROE (TTM)

AKTS-3080.0%

KURA-20718.0%

ROA (TTM)

AKTS-2531.0%

KURA-4517.0%

ROIC (TTM)

AKTS-3080.0%

KURA-19400.0%

Cash

AKTS$82M

KURA$70M

Debt

AKTS$0

KURA$10M

Net Cash/Debt

AKTS$82M

KURA$60M

Current Ratio (TTM)

AKTS16.33x

KURA4.73x

Quick Ratio (TTM)

AKTS16.10x

KURA4.47x

Debt/Equity (TTM)

AKTS0.00x

KURA0.20x

Debt/Assets (TTM)

AKTS0.0%

KURA0.0%

Interest Coverage (TTM)

AKTSN/A

KURAN/A

Net Debt/EBITDA (TTM)

AKTS0.00x

KURA0.00x

Beta

AKTS160.56

KURA0.53

52W Performance

AKTS18688.8%

KURA5.2%

YTD Performance

AKTS-19.0%

KURA2.6%

% from 52W High

AKTS-46.9%

KURA-23.7%

% from 52W Low

AKTS907400.0%

KURA44.1%

Asset Turnover (TTM)

AKTS0.03x

KURA0.12x

FCF Yield (TTM)

AKTS-12.6%

KURA-12.5%

Earnings Yield (TTM)

AKTS-11.0%

KURA-31.5%

Dividend Yield (TTM)

AKTSN/A

KURAN/A

Rule of 40

AKTS-878.2

KURA-159.3

EV/GP/RG

AKTSN/A

KURA0.09

Ticker research

View AKTS research View KURA research

Metric	AKTS Aktis Oncology Inc	KURA Kura Oncology Inc
Market & Valuation
Market Cap	$969M	$941M
Enterprise Value	$887M	$881M
Price	$18.15	$10.60
P/E Ratio	N/A	N/A
P/S Ratio	73.94x	12.18x
EV/Sales	67.65x	11.40x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.12x	19.56x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.29x	-7.50x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	99.47x	6.49x
Revenue & Growth
Revenue (TTM)	$13M	$77M
Revenue Growth (YoY)	49.9%	-7.3%
Forward Rev Growth	-9.8%	106.3%
Profitability
Gross Margin (TTM)	0.0%	72.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-934.0%	-410.2%
Net Margin (TTM)	-810.2%	-384.3%
FCF Margin (TTM)	-928.1%	-152.1%
Net Income (TTM)	$-106M	$-297M
FCF (TTM)	$-122M	$-117M
EPS (TTM)	-$1.92	-$3.34
ROE (TTM)	-3080.0%	-20718.0%
ROA (TTM)	-2531.0%	-4517.0%
ROIC (TTM)	-3080.0%	-19400.0%
Financial Health
Cash	$82M	$70M
Debt	$0	$10M
Net Cash/Debt	$82M	$60M
Current Ratio (TTM)	16.33x	4.73x
Quick Ratio (TTM)	16.10x	4.47x
Debt/Equity (TTM)	0.00x	0.20x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	160.56	0.53
52W Performance	18688.8%	5.2%
YTD Performance	-19.0%	2.6%
% from 52W High	-46.9%	-23.7%
% from 52W Low	907400.0%	44.1%
Efficiency & Yields
Asset Turnover (TTM)	0.03x	0.12x
FCF Yield (TTM)	-12.6%	-12.5%
Earnings Yield (TTM)	-11.0%	-31.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-878.2	-159.3
EV/GP/RG	N/A	0.09
Ticker research	View AKTS research	View KURA research